These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 29618920

  • 1. Vitreous levels of apolipoprotein A1 and retinol binding protein 4 in human rhegmatogenous retinal detachment associated with choroidal detachment.
    Ding N, Luo S, Yu J, Zhou Y, Wu Z.
    Mol Vis; 2018; 24():252-260. PubMed ID: 29618920
    [Abstract] [Full Text] [Related]

  • 2. Metabolomic Analysis of Human Vitreous in Rhegmatogenous Retinal Detachment Associated With Choroidal Detachment.
    Yu M, Wu Z, Zhang Z, Huang X, Zhang Q.
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5706-13. PubMed ID: 26313305
    [Abstract] [Full Text] [Related]

  • 3. Identification of inflammatory mediators in patients with rhegmatogenous retinal detachment associated with choroidal detachment.
    Dai Y, Wu Z, Sheng H, Zhang Z, Yu M, Zhang Q.
    Mol Vis; 2015 Aug; 21():417-27. PubMed ID: 26015767
    [Abstract] [Full Text] [Related]

  • 4. Changes in the postoperative foveal avascular zone in patients with rhegmatogenous retinal detachment associated with choroidal detachment.
    Xu C, Wu J, Feng C.
    Int Ophthalmol; 2020 Oct; 40(10):2535-2543. PubMed ID: 32468430
    [Abstract] [Full Text] [Related]

  • 5. Chemokine CXCL-1: activity in the vitreous during proliferative vitreoretinopathy.
    Symeonidis C, Androudi S, Georgalas I, Tzamalis A, Chalvatzis N, Rotsos T, Souliou E, Diza E, Dimitrakos SA.
    Clin Exp Immunol; 2015 Aug; 181(2):338-42. PubMed ID: 25766782
    [Abstract] [Full Text] [Related]

  • 6. Vitreous levels of Lipocalin-2 on patients with primary rhegmatogenous retinal detachment.
    Batsos G, Christodoulou E, Vartholomatos G, Galanis P, Stefaniotou M.
    PLoS One; 2019 Aug; 14(12):e0227266. PubMed ID: 31891637
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification of Potential Biomarkers for Rhegmatogenous Retinal Detachment Associated with Choroidal Detachment by Vitreous iTRAQ-Based Proteomic Profiling.
    Wu Z, Ding N, Yu M, Wang K, Luo S, Zou W, Zhou Y, Yan B, Jiang Q.
    Int J Mol Sci; 2016 Dec 07; 17(12):. PubMed ID: 27941623
    [Abstract] [Full Text] [Related]

  • 9. Vitreous levels of oxidative stress biomarkers and the radical-scavenger α1-microglobulin/A1M in human rhegmatogenous retinal detachment.
    Cederlund M, Ghosh F, Arnér K, Andréasson S, Akerström B.
    Graefes Arch Clin Exp Ophthalmol; 2013 Mar 07; 251(3):725-32. PubMed ID: 22829194
    [Abstract] [Full Text] [Related]

  • 10. Anatomic Outcomes and Prognostic Factors of Vitrectomy in Patients with Primary Rhegmatogenous Retinal Detachment Associated with Choroidal Detachment.
    Yu Y, Yue Y, Tong N, Zheng P, Liu W, An M.
    Curr Eye Res; 2019 Mar 07; 44(3):329-333. PubMed ID: 30362843
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Amino acid and vascular endothelial growth factor levels in subretinal fluid in rhegmatogenous retinal detachment.
    Yalcinbayir O, Buyukuysal RL, Gelisken O, Buyukuysal C, Can B.
    Mol Vis; 2014 Mar 07; 20():1357-65. PubMed ID: 25352742
    [Abstract] [Full Text] [Related]

  • 14. Extent of Detached Retina and Lens Status Influence Intravitreal Protein Expression in Rhegmatogenous Retinal Detachment.
    Pollreisz A, Sacu S, Eibenberger K, Funk M, Kivaranovic D, Zlabinger GJ, Georgopoulos M, Schmidt-Erfurth U.
    Invest Ophthalmol Vis Sci; 2015 Aug 07; 56(9):5493-502. PubMed ID: 26284555
    [Abstract] [Full Text] [Related]

  • 15. Correlation of transforming growth factor β-1 vitreous levels with clinical severity of proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment.
    Palomares-Ordóñez JL, Sánchez-Ramos JA, Ramírez-Estudillo JA, Robles-Contreras A.
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Jan 07; 94(1):12-17. PubMed ID: 30309666
    [Abstract] [Full Text] [Related]

  • 16. Elevated erythropoietin in vitreous of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
    Wang ZY, Shen LJ, Zhao KK, Song ZM, Qu J.
    Ophthalmic Res; 2009 Jan 07; 42(3):138-40. PubMed ID: 19602911
    [Abstract] [Full Text] [Related]

  • 17. Comparison of Chemokine CXCL-1 and Interleukin-6 Concentrations in the Subretinal Fluid and Vitreous in Rhegmatogenous Retinal Detachment.
    Symeonidis C, Rotsos T, Matsou A, Dermenoudi M, Georgalas I, Tsinopoulos I, Makri O, Souliou E, Dimitrakos SA.
    Ocul Immunol Inflamm; 2021 Feb 17; 29(2):355-361. PubMed ID: 31661651
    [Abstract] [Full Text] [Related]

  • 18. Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment.
    Balogh A, Milibák T, Szabó V, Nagy ZZ, Kaarniranta K, Resch MD.
    BMC Ophthalmol; 2020 Dec 28; 20(1):491. PubMed ID: 33371882
    [Abstract] [Full Text] [Related]

  • 19. Position of macula lutea and presence of proliferative vitreoretinopathy affect vitreous cytokine expression in rhegmatogenous retinal detachment.
    Balogh A, Milibák T, Szabó V, Nagy ZZ, Resch MD.
    PLoS One; 2020 Dec 28; 15(6):e0234525. PubMed ID: 32542038
    [Abstract] [Full Text] [Related]

  • 20. Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment.
    Loukovaara S, Lehti K, Robciuc A, Pessi T, Holopainen JM, Koli K, Immonen I, Keski-Oja J.
    Graefes Arch Clin Exp Ophthalmol; 2014 Jun 28; 252(6):881-8. PubMed ID: 24218041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.